ArticleTrials2026
The use of age-friendly implementation aids in self-management skills in elderly patients with chronic heart failure: a randomized controlled trial study protocol for a randomized controlled trial.
Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundRecognizing symptoms and responding appropriately can reduce emergency department visits, heart failure hospitalization rates, and all-cause mortality. However, elderly patients with chronic heart failure face greater challenges in symptom recognition due to physiological decline and multiple comorbidities, which significantly impact their prognosis. Therefore, we conducted a randomized controlled trial to evaluate the effects of an age-friendly implementation tool on elderly patients' symptom self-management capabilities, delayed medical care rates, and emergency department visit rates, providing evidence-based guidance for optimizing health management strategies in this population.
methodsThis protocol describes a parallel randomized controlled trial (RCT) in which evaluators and analysts used a blinded method to target elderly patients over 60 years of age with heart failure. The trial compared an intervention group (n = 74) with a conventional treatment group (n = 74). The primary outcomes are self-reported symptom recognition ability assessed via the Dutch Heart Failure Knowledge Questionnaire and self-care ability assessed via the European Heart Failure Self-Care Behavior Questionnaire. The secondary outcomes include quality of life (QoL) measured via the EuroQol-5D (EQ-5D) and delayed medical care rates. All these data will be collected at baseline, at discharge, at 3 months, and at 6 months to test the effectiveness of the age-friendly execution assistance tool. DISCUSSION: This study will confirm that elderly-friendly tools can effectively enhance self-management capabilities for elderly CHF patients, significantly reducing delayed medical care and emergency department visits. We anticipate that this tool, tailored to the physiological and cognitive characteristics of the elderly population, will provide evidence-based references for precision health management and interventions for elderly patients with similar chronic conditions. ETHICS AND DISSEMINATION: The Medical Ethics Committee of Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine (20250513), approved this study. All participants signed a written informed consent form prior to the baseline assessment. Once the final report of the study is completed, the results will be widely disseminated in peer-reviewed journals. The public will be informed of the study results through media reports, briefings, and other means.
trial registrationChiCTR2500106241. Registered on 21 July 2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.